Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by CravenRaven101on Nov 07, 2011 5:43pm

197 Views

Post# 19216614

RE: Low Trading Volumes Mean Someting

The only thing people are laughing at on this board is you Germini... FOR the record I haven't held an ONC stock in my portfolio since last spring... did you manage to slip the boys with the white coats for a few minutes so you could get your message out ??? LOL...LOl...LOL... OR is your wifey attending to a family emergency... in either case... put the keyboard down... and walk away... YOU have zero credibility here

it's MY opinion git yer own.

Bullboard Posts

The top 5 Canadian small-cap AI stocks